Teladoc Health Inc (NYSE:TDOC) Director William H. Frist Sells 740 Shares

Teladoc Health Inc (NYSE:TDOC) Director William H. Frist sold 740 shares of the firm’s stock in a transaction dated Friday, September 11th. The stock was sold at an average price of $199.41, for a total value of $147,563.40. Following the transaction, the director now directly owns 6,158 shares in the company, valued at approximately $1,227,966.78. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink.

TDOC stock opened at $197.19 on Wednesday. The firm has a 50 day moving average of $208.11 and a 200-day moving average of $182.40. Teladoc Health Inc has a 12-month low of $60.05 and a 12-month high of $253.00. The company has a current ratio of 11.36, a quick ratio of 11.36 and a debt-to-equity ratio of 0.73. The company has a market cap of $15.82 billion, a price-to-earnings ratio of -152.12 and a beta of 0.30.

Teladoc Health (NYSE:TDOC) last posted its quarterly earnings results on Wednesday, July 29th. The health services provider reported ($0.34) earnings per share (EPS) for the quarter, missing the Zacks’ consensus estimate of ($0.23) by ($0.11). Teladoc Health had a negative net margin of 13.22% and a negative return on equity of 9.54%. The company had revenue of $241.03 million for the quarter, compared to analyst estimates of $220.49 million. During the same quarter in the previous year, the business posted ($0.41) earnings per share. Teladoc Health’s revenue was up 85.0% on a year-over-year basis. Sell-side analysts forecast that Teladoc Health Inc will post -1.4 earnings per share for the current fiscal year.

Several equities analysts have issued reports on the company. Deutsche Bank raised their price objective on Teladoc Health from $225.00 to $239.00 and gave the stock a “buy” rating in a report on Friday, September 4th. They noted that the move was a valuation call. Cowen reaffirmed a “buy” rating and set a $197.00 price objective on shares of Teladoc Health in a report on Wednesday, July 8th. Cantor Fitzgerald raised their price objective on Teladoc Health from $165.00 to $210.00 and gave the stock a “neutral” rating in a report on Thursday, July 30th. Barclays raised their price objective on Teladoc Health from $200.00 to $230.00 and gave the stock an “equal weight” rating in a report on Thursday, July 30th. Finally, Zacks Investment Research lowered Teladoc Health from a “buy” rating to a “hold” rating and set a $171.00 price objective on the stock. in a report on Thursday, May 28th. Thirteen equities research analysts have rated the stock with a hold rating and sixteen have given a buy rating to the company’s stock. The stock has a consensus rating of “Buy” and a consensus price target of $211.75.

Institutional investors and hedge funds have recently modified their holdings of the company. Marshall Wace North America L.P. bought a new stake in shares of Teladoc Health during the 1st quarter worth $35,000. Public Employees Retirement Association of Colorado lifted its holdings in shares of Teladoc Health by 1.3% during the 1st quarter. Public Employees Retirement Association of Colorado now owns 10,193 shares of the health services provider’s stock worth $1,580,000 after acquiring an additional 135 shares during the period. Aperio Group LLC lifted its holdings in shares of Teladoc Health by 62.7% during the 1st quarter. Aperio Group LLC now owns 17,617 shares of the health services provider’s stock worth $2,731,000 after acquiring an additional 6,789 shares during the period. Rhumbline Advisers lifted its holdings in shares of Teladoc Health by 2.5% during the 1st quarter. Rhumbline Advisers now owns 105,713 shares of the health services provider’s stock worth $16,387,000 after acquiring an additional 2,616 shares during the period. Finally, First Trust Advisors LP lifted its holdings in shares of Teladoc Health by 60.3% during the 1st quarter. First Trust Advisors LP now owns 66,461 shares of the health services provider’s stock worth $10,302,000 after acquiring an additional 25,009 shares during the period. 87.39% of the stock is owned by institutional investors and hedge funds.

About Teladoc Health

Teladoc Health, Inc provides telehealth services. It offers a portfolio of services and solutions covering 450 medical subspecialties, such as flu and upper respiratory infections, cancer, and congestive heart failure. The company provides its services through mobile devices, the Internet, video, and phone.

Further Reading: Why do companies issue stock splits?

Insider Buying and Selling by Quarter for Teladoc Health (NYSE:TDOC)

Receive News & Ratings for Teladoc Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teladoc Health and related companies with MarketBeat.com's FREE daily email newsletter.